| Cancer and Alzheimer’s disease inverse relationship: An age-associated diverging derailment of shared pathways C Lanni, M Masi, M Racchi, S Govoni Molecular Psychiatry 26 (1), 280-295, 2021 | 96 | 2021 |
| Endocrine-disrupting chemicals’(EDCs) effects on tumour microenvironment and cancer progression: emerging contribution of RACK1 E Buoso, M Masi, M Racchi, E Corsini International Journal of Molecular Sciences 21 (23), 9229, 2020 | 44 | 2020 |
| OXER1 and RACK1-associated pathway: A promising drug target for breast cancer progression M Masi, E Garattini, M Bolis, D Di Marino, L Maraccani, E Morelli, ... Oncogenesis 9 (12), 105, 2020 | 30 | 2020 |
| Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer E Buoso, M Masi, A Long, C Chiappini, C Travelli, S Govoni, M Racchi British journal of pharmacology 179 (12), 2813-2828, 2022 | 23 | 2022 |
| Molecular characterization of membrane steroid receptors in hormone-sensitive cancers M Masi, M Racchi, C Travelli, E Corsini, E Buoso Cells 10 (11), 2999, 2021 | 22 | 2021 |
| Effect of estrogen-active compounds on the expression of RACK1 and immunological implications E Buoso, M Masi, V Galbiati, A Maddalon, M Iulini, M Kenda, ... Archives of toxicology 94, 2081-2095, 2020 | 21 | 2020 |
| Effects of bisphenols on RACK1 expression and their immunological implications in THP-1 cells E Buoso, M Kenda, M Masi, P Linciano, V Galbiati, M Racchi, MS Dolenc, ... Frontiers in pharmacology 12, 743991, 2021 | 18 | 2021 |
| The coupling of RACK1 with the beta isoform of the glucocorticoid receptor promotes resilience to chronic stress exposure P Brivio, E Buoso, M Masi, MT Gallo, P Gruca, M Lason, E Litwa, M Papp, ... Neurobiology of Stress 15, 100372, 2021 | 12 | 2021 |
| Effects of endocrine disrupting chemicals on the expression of RACK1 and LPS-induced THP-1 cell activation M Masi, A Maddalon, M Iulini, P Linciano, V Galbiati, M Marinovich, ... Toxicology 480, 153321, 2022 | 11 | 2022 |
| Effects of endocrine active contaminating pesticides on RACK1 expression and immunological consequences in THP-1 cells A Maddalon, M Masi, M Iulini, P Linciano, V Galbiati, M Marinovich, ... Environmental toxicology and pharmacology 95, 103971, 2022 | 11 | 2022 |
| GSK-3β allosteric inhibition: a dead end or a new pharmacological frontier? B Balboni, M Masi, W Rocchia, S Girotto, A Cavalli International Journal of Molecular Sciences 24 (8), 7541, 2023 | 5 | 2023 |
| Proteostasis deregulation in neurodegeneration and its link with stress granules: focus on the scaffold and ribosomal protein RACK1 M Masi, A Attanzio, M Racchi, B Wolozin, S Borella, F Biundo, E Buoso Cells 11 (16), 2590, 2022 | 5 | 2022 |
| The labyrinthine landscape of APP processing: state of the art and possible novel soluble APP-related molecular players in traumatic brain injury and neurodegeneration M Masi, F Biundo, A Fiou, M Racchi, A Pascale, E Buoso International Journal of Molecular Sciences 24 (7), 6639, 2023 | 2 | 2023 |
| Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthetic lethality in pancreatic cancer S Girotto, M Masi, L Poppi, V Previtali, S Nelson, G Varignani, ... | | 2024 |
